Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
159 studies found for:    psoriatic arthritis | psoriatic arthritis
Show Display Options
Rank Status Study
21 Completed Differential Clinical and Serologic Response in Psoriasis and Psoriatic Arthritis to Drug Treatment
Condition: Psoriatic Arthritis
Intervention:
22 Completed
Has Results
Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care
Conditions: Rheumatoid Arthritis;   Psoriatic Arthritis;   Ankylosing Spondylitis
Intervention:
23 Recruiting Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: 210 mg brodalumab;   Drug: 140 mg brodalumab;   Drug: Placebo
24 Completed Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Biological: AIN457A
25 Completed
Has Results
Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice
Conditions: Psoriasis;   Psoriatic Arthritis
Intervention: Procedure: lab draws and imaging
26 Recruiting Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: Open  label H.P. Acthar Gel
27 Completed Rituxan With or Without Methotrexate in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: Rituximab
28 Completed Effect of Exercise and Diet on Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Other: Diet;   Other: Exercise;   Other: Diet and Exercise;   Other: Healthy Lifestyle (Control) Group
29 Completed Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Infliximab;   Drug: Etanercept
30 Recruiting Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: 210 mg brodalumab;   Drug: 140 mg brodalumab;   Drug: Placebo
31 Completed Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Biological: AIN457;   Biological: Placebo
32 Recruiting Multiple Dose Study of UCB4940 in Subjects With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: UCB4940 40 mg;   Drug: UCB4940 80 mg;   Drug: UCB4940 160 mg;   Drug: UCB4940 240 mg;   Drug: UCB4940 320 mg;   Drug: UCB4940 560 mg;   Other: Placebo
33 Recruiting A Study of Golimumab in Participants With Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Placebo;   Drug: Golimumab
34 Completed A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: Adalimumab (HUMIRA®)
35 Not yet recruiting Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Etanercept + Oral Methotrexate;   Drug: Etanercept + Placebo for Methotrexate;   Drug: Oral Methotrexate + Placebo for Etanercept
36 Completed
Has Results
An Effectiveness and Safety Study of CNTO 1275 in Patients With Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: CNTO 1275 63 mg;   Drug: Placebo
37 Not yet recruiting Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA)
Condition: Psoriatic Arthritis
Interventions: Drug: Guselkumab;   Drug: Ustekinumab;   Drug: Placebo
38 Completed Study Evaluating Anxiety and Depression in Patients With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention:
39 Recruiting 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Biological: Secukinumab;   Biological: Placebo
40 Withdrawn A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Conditions: Rheumatoid Arthritis;   Psoriatic Arthritis;   Ankylosing Spondylitis
Intervention: Drug: No intervention

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years